This test determines an individual’s genetic risk associated with the Apolipoprotein E gene. ApoE is involved in the metabolism of cholesterol and triglycerides, and variants in this gene can have clinically relevant implications for disease risk as well as one’s response to statin therapy, dietary fat, and other risk factors (eg., smoking and alcohol consumption). Approximately 45% of individuals carry one or more of the high risk variants within the ApoE gene. The results of the genotyping of Apolipoprotein E have important implications in the treatment strategies for individual patients in reducing cardiovascular disease risk.
What does ApoE do?
- ApoE plays a role in the transport and metabolism of plasma lipoproteins (which carry cholesterol).
- The role of ApoE is to bind to cellular receptors and mediate clearance of the lipoproteins and their remnants from the bloodstream.
- ApoE functions mainly in the liver and brain but is also found in other tissues throughout the body.
What does ApoE Genotype Mean for Cardiovascular Disease Risk?
There are 6 possible ApoE genotypes:
- ApoE genotyping is best used in conjunction with additional lipid profile monitoring
- ApoE genotyping is a useful tool to help determine the best dietary and pharmaceutical approach to maintaining healthy lipid levels
- Maintaining healthy lipid levels can decrease the risk of cardiovascular disease, strokes, and other health problems
“SpectraCell Micronutrient Test is a unique, scientifically-based nutrient evaluation of specific deficiencies that allows for targeted treatment. The detection of micronutrient deficiencies using this test offers a functional and biochemically unique approach to the prevention and treatment of many diseases in which the root cause originated with nutritional deficiency and subsequent downstream of cellular dysfunction and illness.”
Mark Houston, M.D., M.S., SCH, ABAAM, FACP, FAHA
“SpectraCell's micronutrient test allows me to diagnose specific functional deficiencies and subsequently compound supplements appropriate for the individual needs of my patients.”
Michael O'Neal, Primary Care Team Physician
Toronto Blue Jays – MLB
"As an interventional cardiologist and electrophysiologist dedicated to the advancement of cardiovascular health, I have come to appreciate the need for individualizing our approach to patient care. I have relied heavily upon SpectraCell's Micronutrient Test for the better part of the last decade. It gives me the ability to treat patients on a targeted and individualized level, thus eliminating the guesswork."
Seth Baum, M.D.
Cardiologist, VitalRemedy - Boca Raton, FL